Last reviewed · How we verify

NCT05195671

Implications of Ethics Determinant on Dentistry and Pharmacy Research

Completed Last updated 19 January 2022
What this trial tests

trial testing Review in Review, Research Peer in 131 participants. Completed in 10 December 2021.

Timeline
1 October 2021
Primary endpoint
1 December 2021
10 December 2021

Quick facts

Lead sponsorMisr International University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment131
Start date1 October 2021
Primary completion1 December 2021
Estimated completion10 December 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Misr International University

Who can join

Eligibility, any sex, with Review, Research Peer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The ethical review of dental and pharmacy research protocols has its own challenges facing the institutional ethical committees. Seemingly low risk procedure might pose controversies among committees' members. The aim of this article is to describe some of the ethical concerns, particular to dental and pharmacy research that an ethics committee could face while reviewing dental research.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Review

Trials testing the same drug.

Other Misr International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05195671.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing